[
    [
        {
            "time": "",
            "original_text": "人才难求！创新药企井喷致人才争夺愈烈，本土头部企业研发人员薪酬已与跨国企业比肩",
            "features": {
                "keywords": [
                    "人才",
                    "创新药企",
                    "研发人员",
                    "薪酬"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "人才难求！创新药企井喷致人才争夺愈烈，本土头部企业研发人员薪酬已与跨国企业比肩",
                "Correlation": 8,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 6,
                "Duration": 7,
                "Entity_Density": 5,
                "Market_Scope": 8,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "浅谈创新药两大模式：First in Class和Fast Follow",
            "features": {
                "keywords": [
                    "创新药",
                    "First in Class",
                    "Fast Follow"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "浅谈创新药两大模式：First in Class和Fast Follow",
                "Correlation": 6,
                "Sentiment": 5,
                "Importance": 5,
                "Impact": 4,
                "Duration": 5,
                "Entity_Density": 3,
                "Market_Scope": 7,
                "Time_Proximity": 6,
                "Headline_Structure": 6,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "核心资产板块呈现分化趋势，逢低关注白酒、医药、大金融",
            "features": {
                "keywords": [
                    "核心资产",
                    "分化趋势",
                    "白酒",
                    "医药",
                    "大金融"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "白酒",
                    "医药",
                    "金融"
                ],
                "causal_factor": "false",
                "causal_impact": "",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "核心资产板块呈现分化趋势，逢低关注白酒、医药、大金融",
                "Correlation": 5,
                "Sentiment": 6,
                "Importance": 6,
                "Impact": 5,
                "Duration": 6,
                "Entity_Density": 4,
                "Market_Scope": 9,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        }
    ]
]